Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease

被引:6
|
作者
Zeynalzadeh, Monica [3 ,4 ]
Tafazoli, Alireza [3 ]
Aarabi, Azadeh [2 ]
Moghaddassian, Morteza [5 ]
Ashrafzadeh, Farah [6 ]
Houshmand, Massoud [7 ]
Taghehchian, Negin [2 ]
Abbaszadegan, Mohammad Reza [1 ,2 ]
机构
[1] Mashhad Univ Med Sci, Avicenna Res Inst, Immunol Res Ctr, Med Genet Res Ctr, Mashhad 9196773117, Iran
[2] Mashhad Univ Med Sci, Avicenna Res Inst, Immunol Res Ctr, Div Human Genet, Mashhad 9196773117, Iran
[3] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Iran
[4] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[5] Univ Toronto, Fac Appl Sci & Engn, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada
[6] Mashhad Univ Med Sci, Qaem Med Ctr, Dept Pediat Neurol, Mashhad, Iran
[7] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran
来源
关键词
BCCAs; BCKDH; molecular genetic tests; MSUD; ALPHA-KETOACID DEHYDROGENASE; CRYSTAL-STRUCTURE; FOUNDER MUTATION; IDENTIFICATION; E1-ALPHA; DISORDERS; MARRIAGES; COMPLEX; CODON;
D O I
10.1515/jpem-2017-0305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Maple syrup urine disease (MSUD) is a rare metabolic autosomal recessive disorder caused by dysfunction of the branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex. Mutations in the BCKDHA, BCKDHB and DBT genes are responsible for MSUD. The current study analyzed seven Iranian MSUD patients genetically and explored probable correlations between their genotype and phenotype. Methods: The panel of genes, including BCKDHA, BCKDHB and DBT, was evaluated, using routine the polymerase chain reaction (PCR)-sequencing method. In addition, protein modeling (homology and threading modeling) of the deduced novel mutations was performed. The resulting structures were then analyzed, using state-of-the-art bioinformatics tools to better understand the structural and functional effects caused by mutations. Results: Seven mutations were detected in seven patients, including four novel pathogenic mutations in BCKDHA (c.1198delA, c.629C>T), BCKDHB (c.652C>T) and DBT (c.1150A>G) genes. Molecular modeling of the novel mutations revealed clear changes in the molecular energy levels and stereochemical traits of the modeled proteins, which may be indicative of strong correlations with the functional modifications of the genes. Structural deficiencies were compatible with the observed phenotypes. Conclusions: Any type of MSUD can show heterogeneous clinical manifestations in different ethnic groups. Comprehensive molecular investigations would be necessary for differential diagnosis.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 50 条
  • [41] Developing AAV-Mediated Clinically Translatable Gene Therapy for Maple Syrup Urine Disease (MSUD) Caused by BCKDHA Mutations in a Bovine Model
    Wang, Jiaming
    Puffenberger, Erik
    Beever, Jonathan
    GrayEdwards, Heather
    Li, Jia
    Wynn, R. Max
    Chuang, David T.
    Wang, Dan
    Strauss, Kevin A.
    Gao, Guangping
    MOLECULAR THERAPY, 2020, 28 (04) : 411 - 412
  • [42] Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations
    Abiri, Maryam
    Saei, Hassan
    Eghbali, Maryam
    Karamzadeh, Razieh
    Shirzadeh, Tina
    Sharifi, Zohreh
    Zeinali, Sirous
    METABOLIC BRAIN DISEASE, 2019, 34 (04) : 1145 - 1156
  • [43] Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients; insilico analysis of novel mutations
    Abiri, M.
    Ahan, H. Saei
    Eghbali, M.
    Karamzadeh, R.
    Shirzadeh, T.
    Sharifi, Z.
    Zeinali, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1348 - 1348
  • [44] MAPLE-SYRUP-URINE-DISEASE (MSUD) - SCREENING FOR KNOWN MUTATIONS IN ITALIAN PATIENTS
    PARRELLA, T
    SURREY, S
    IOLASCON, A
    SARTORE, M
    HEIDENREICH, R
    DIAMOND, G
    PONZONE, A
    GUARDAMAGNA, O
    BURLINA, AB
    CERONE, R
    PARINI, R
    DIONISIVICI, C
    RAPPAPORT, E
    FORTINA, P
    JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (06) : 652 - 660
  • [45] Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations
    Maryam Abiri
    Hassan Saei
    Maryam Eghbali
    Razieh Karamzadeh
    Tina Shirzadeh
    Zohreh Sharifi
    Sirous Zeinali
    Metabolic Brain Disease, 2019, 34 : 1145 - 1156
  • [46] Developing AAV-Mediated Clinically Translatable Gene Therapy for Maple Syrup Urine Disease (MSUD) Caused by BCKDHA Mutations in a Bovine Model
    Wang, Jiaming
    Wang, Dan
    Beever, Jonathan
    Puffenberger, Erik
    GrayEdwards, Heather
    Strauss, Kevin A.
    Gao, Guangping
    MOLECULAR THERAPY, 2019, 27 (04) : 238 - 239
  • [47] DEVELOPMENTAL PROFILE OF PATIENTS WITH MAPLE SYRUP URINE DISEASE
    NORD, A
    VANDOORNINCK, WJ
    GREENE, C
    JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (06) : 881 - 889
  • [48] Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD)
    Wang, Yue-Ping
    Qi, Man-Long
    Li, Ting-Ting
    Zhao, Yun-Jing
    GENE, 2012, 498 (01) : 112 - 115
  • [49] Maple syrup urine disease due to a new large deletion at BCKDHA caused by non-homologous recombination
    Quental, S.
    Martins, E.
    Vilarinho, L.
    Amorim, A.
    Joao Prata, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : S457 - S460
  • [50] Four novel mutations identified in Norwegian patients result in intermittent maple syrup urine disease when combined with the R301C mutation
    Brodtkorb, Else
    Strand, Janne
    Backe, Paul Hoff
    Lund, Anne Marie
    Bjoras, Magnar
    Rootwelt, Terje
    Rootwelt, Helge
    Woldseth, Berit
    Eide, Lars
    MOLECULAR GENETICS AND METABOLISM, 2010, 100 (04) : 324 - 332